Top

Published in:

01-07-2020 | Neurological Tests | Letter to the Editors

Anti-Hu-associated paraneoplastic syndromes triggered by immune-checkpoint inhibitor treatment

Authors: Neus Mongay-Ochoa, Alberto Vogrig, Sergio Muñiz-Castrillo, Jerome Honnorat

Excerpt

Dear Sirs, …

Available only for authorised users

Graus F, Dalmau J (2019) Paraneoplastic neurological syndromes in the era of immune-checkpoint inhibitors. Nat Rev Clin Oncol. https://doi.org/10.1038/s41571-019-0194-4 CrossRefPubMed

Yshii LM, Gebauer CM, Pignolet B et al (2016) CTLA4 blockade elicits paraneoplastic neurological disease in a mouse model. Brain 139:2923–2934. https://doi.org/10.1093/brain/aww225 CrossRefPubMed

Vogrig A, Fouret M, Joubert B et al (2019) Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors. Neurol Neuroimmunol Neuroinflammation 6:e604. https://doi.org/10.1212/NXI.0000000000000604 CrossRef

Vogrig A, Gigli GL, Segatti S et al (2019) Epidemiology of paraneoplastic neurological syndromes: a population-based study. J Neurol. https://doi.org/10.1007/s00415-019-09544-1 CrossRefPubMed

Simard C, Vogrig A, Joubert B et al (2020) Clinical spectrum and diagnostic pitfalls of neurologic syndromes with Ri antibodies. Neurol Neuroimmunol Neuroinflammation. https://doi.org/10.1212/NXI.0000000000000699 CrossRef

Vogrig A, Muñiz-Castrillo S, Joubert B et al (2020) Central nervous system complications associated with immune checkpoint inhibitors. J Neurol Neurosurg Psychiatry. https://doi.org/10.1136/jnnp-2020-323055 CrossRefPubMed

Hottinger AF (2016) Neurologic complications of immune checkpoint inhibitors. Curr Opin Neurol 29:806–812. https://doi.org/10.1097/WCO.0000000000000391 CrossRefPubMed

Papadopoulos KP, Romero RS, Gonzalez G et al (2018) Anti-Hu-associated autoimmune limbic encephalitis in a patient with PD-1 inhibitor-responsive myxoid chondrosarcoma. Oncologist 23:118–120. https://doi.org/10.1634/theoncologist.2017-0344 CrossRefPubMed

Matsuoka H, Kimura H, Koba H et al (2018) Nivolumab-induced limbic encephalitis with anti-Hu antibody in a patient with advanced pleomorphic carcinoma of the lung. Clin Lung Cancer 19:e597–e599. https://doi.org/10.1016/j.cllc.2018.04.009 CrossRefPubMed

10.

Raskin J, Masrori P, Cant A et al (2017) Recurrent dysphasia due to nivolumab-induced encephalopathy with presence of Hu autoantibody. Lung Cancer Amst Neth 109:74–77. https://doi.org/10.1016/j.lungcan.2017.05.002 CrossRef

Title: Anti-Hu-associated paraneoplastic syndromes triggered by immune-checkpoint inhibitor treatment
Authors: Neus Mongay-Ochoa
Alberto Vogrig
Sergio Muñiz-Castrillo
Jerome Honnorat
Publication date: 01-07-2020
Publisher: Springer Berlin Heidelberg
Keywords: Neurological Tests
SCLC
Paraneoplastic Syndromes
Magnetic Resonance Imaging of the Spine
SCLC
Checkpoint Inhibitors
Published in: Journal of Neurology / Issue 7/2020
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-020-09940-y